Watson Pharmaceuticals (WPI +1.3%) is on track to announce a deal to buy Swiss-based Actavis for...

|By:, SA News Editor

Watson Pharmaceuticals (WPI +1.3%) is on track to announce a deal to buy Swiss-based Actavis for ~$6B by the end of April, creating one of the world's biggest producers of generic drugs, Reuters reports. Watson believes a move would help it compete more effectively against rivals like Teva and Novartis unit Sandoz.